Where it is registered
Each register with its number of medicines and a few of them.
Saudi Arabia
SFDA · 1 medicine · Historical list
All medicines with Pneumococcal
Every register, a page at a time. Strengths and packs are on each medicine’s page.
42 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Pneumovax 23 | United States | 25UG/.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Pneumovax 23 | United States | 25UG/.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Prevnar 20 | United States | 0.5 ML | Injection | Marketed | Wyeth Pharmaceuticals LLC |
| Vaxneuvance | United States | 2.0UG | Injection | Marketed | Merck Sharp & Dohme LLC |
| Capvaxive | United States | 84UG/.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Pneumovax 23 Pneumococcal Vaccine Polyvalent | Saudi Arabia | Authorised | Merck Sharp and Dohme LLC | ||
| Prevenar 13Combination | Saudi Arabia | Authorised | Pfizer | ||
| Pneumovax 23 | Singapore | 25mcg/0.5ml each | injection | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Pneumovax 23 | New Zealand | Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) | Funded | ||
| Prevenar 13 | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Vaxneuvance | European Union | Authorised | Merck Sharp & Dohme B.V. | ||
| Prevenar 20 (previously Apexxnar) | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Pneumovax 23 (Prefilled Syringe) | Singapore | 25mcg/0.5ml of each type | injection | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Capvaxive | European Union | Authorised | Merck Sharp & Dohme B.V. | ||
| Synflorix | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Prevnar 20Combination | Canada | 51 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 4.4 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML + 2.2 MCG / 0.5 ML | Suspension | Marketed | Pfizer Canada Ulc |
| VaxneuvanceCombination | Canada | 30 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML + 4 MCG / 0.5 ML + 2 MCG / 0.5 ML + 2 MCG / 0.5 ML | Suspension | Marketed | Merck Canada INC |
| prevnar | United States | 0.5ML/VIAL | Injection | Withdrawn | Wyeth Pharmaceuticals LLC |
| Prevnar 13 | United States | 0.5ML | Injection | Withdrawn | Wyeth Pharmaceuticals LLC |
| CapvaxiveCombination | Canada | 65 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML + 4 MCG / 0.5 ML | Solution | Marketed | Merck Canada INC |
| Prevenar 13 Suspension For InjectionCombination | Singapore | 32mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 4.4mcg + 2.2mcg + 2.2mcg | injection, suspension | Authorised | Pfizer Private Limited |
| VAXNEUVANCE® Suspension for Injection | Singapore | 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 4μg + 2μg + 2μg | injection, suspension | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Prevenar 20 Suspension for Injection in Single-Dose Pre-Filled Syringe 0.5MLCombination | Singapore | Approx. 51 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 4.4 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml | injection, suspension | Authorised | Pfizer Private Limited |
| CAPVAXIVE Solution for InjectionCombination | Singapore | 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL + 4ug/0.5mL | injection, solution | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Prevenar 13 | New Zealand | Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe | Funded |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1



